TP53 and cancer: For instance, activated AMPK could possibly induce p53 activation and mammalian target of rapamycin (mTOR) complex 1 (mTORC1) in-activation [13], as well as autophagy induction [14–17] and oncogenic protein degradation [18], which eventually can lead to profound anti-cancer cell activity.